Breaking News Instant updates and real-time market news.

RMED

Ra Medical Systems

$1.73

-0.17 (-8.95%)

14:36
09/12/19
09/12
14:36
09/12/19
14:36

Ra Medical's RESULTS study to gather data over two years, Kraws says

Ra Medical (RMED) develops and commercializes excimer lasers as tools for the treatment of vascular and dermatological diseases. In an exclusive interview with The Fly, the company's President Jeffrey Kraws talked about Ra Medical's RESULTS study: "The study is named RESULTS, and that stands for revascularization rates clinical outcomes with Dabra laser long-term study. With regard to the study, we are conducting it to demonstrate that our Dabra Excimer Laser System delivers effective long-lasting results and a low re intervention rate for patients that suffer from Peripheral arterial disease. There are approximately 17.6M people we estimate in the United States that are afflicted by Peripheral arterial disease and less than 30% of them being treated today. Our study will gather data over two years post-treatment and up to 2,500 patients. Our Dabra laser system is a novel minimally invasive excimer laser photo ablation system that non thermally photochemically ablates channels and vascular blockages. Unlike many of the mechanical acoustic or thermal treatments for Peripheral arterial disease - there are competitors that may damage their arterial walls - our Dabra system treats blockages with minimal vascular trauma, and we hope to obtain results from this two years post-treatment." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.

RMED Ra Medical Systems
$1.73

-0.17 (-8.95%)

05/15/19
MAXM
05/15/19
NO CHANGE
Target $12
MAXM
Buy
Ra Medical Systems price target lowered to $12 from $15 at Maxim
Maxim analyst Anthony Vendetti lowered his price target on Ra Medical Systems to $12, saying that while Q1 revenues topped expectations, earnings and gross margins missed due to manufacturing and production issues in the Vascular segment as well as higher SG&A expenses. The analyst keeps his Buy rating on the stock, but believes that the Vascular segment revenue ramp will "take some time."
08/13/19
PIPR
08/13/19
DOWNGRADE
Target $1.5
PIPR
Neutral
Ra Medical Systems downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien downgraded Ra Medical Systems to Neutral from Overweight and lowered his price target for the shares to $1.50 from $9.00. Despite the dermatology business coming in ahead of expectations in Q2, the company's key vascular franchise came in well short of estimates, O'Brien tells investors in a research note. With the company delaying its quarterly results until the conclusion of an audit committee investigation based on an anonymous tip, and terminating its CEO, the analyst says the uncertainty outweighs his enthusiasm for Ra Medical's technology.
08/13/19
CANT
08/13/19
DOWNGRADE
CANT
Neutral
Ra Medical Systems downgraded to Neutral from Overweight at Cantor Fitzgerald
08/13/19
CANT
08/13/19
DOWNGRADE
Target $2
CANT
Neutral
Cantor downgrades Ra Medical on uncertainty, cuts target to $2 from $10
Cantor Fitzgerald analyst Craig Bijou downgraded Ra Medical Systems to Neutral from Overweight and lowered his price target for the shares to $2 from $10. After the company disclosed inconsistencies in its manufacturing, terminated its CEO and opened an audit committee investigation, the analyst sees "too much uncertainty."

TODAY'S FREE FLY STORIES

EVFM

Evofem

$5.01

-0.065 (-1.28%)

06:39
10/16/19
10/16
06:39
10/16/19
06:39
Initiation
Evofem initiated  »

Evofem assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$267.56

5.73 (2.19%)

06:37
10/16/19
10/16
06:37
10/16/19
06:37
Hot Stocks
Breaking Hot Stocks news story on ASML »

ASML CEO Peter Wennink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

ASML

ASML

$267.56

5.73 (2.19%)

06:37
10/16/19
10/16
06:37
10/16/19
06:37
Earnings
ASML sees Q4 net sales around EUR3.9B »

ASML sees Q4 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

FSCT

ForeScout

$26.13

0.56 (2.19%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Recommendations
ForeScout analyst commentary  »

ForeScout price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Dec

ASML

ASML

$267.56

5.73 (2.19%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Earnings
ASML reports Q3 EPS EUR1.49 vs. EUR1.13 in Q2 »

Reports Q3 net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

FHN

First Horizon

$16.13

0.22 (1.38%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Earnings
First Horizon reports Q3 adjusted EPS 43c, consensus 42c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 07

    Nov

BK

BNY Mellon

$44.37

0.47 (1.07%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Earnings
BNY Mellon reports Q3 EPS $1.07, consensus 99c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BLDR

Builders FirstSource

$21.54

0.96 (4.66%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Upgrade
Builders FirstSource rating change  »

Builders FirstSource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

  • 14

    Nov

NEPT

Neptune Wellness

$3.46

0.135 (4.06%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Hot Stocks
Neptune Wellness announces Sherbrooke facility to use new cold ethanol equipment »

Neptune Wellness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BMCH

BMC Stock Holdings

$26.15

0.94 (3.73%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Upgrade
BMC Stock Holdings rating change  »

BMC Stock Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Hot Stocks
Alexion to acquire Achillion for $6.30 per share in cash »

Alexion Pharmaceuticals…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AVGO

Broadcom

$290.46

8.81 (3.13%)

06:32
10/16/19
10/16
06:32
10/16/19
06:32
Hot Stocks
Broadcom ordered by EU to halt allegedly anticompetitive contract practices »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$35.68

-0.365 (-1.01%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift should rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Hot Stocks
Breaking Hot Stocks news story on Alexion, Achillion »

Alexion to acquire…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

, ORCL

Oracle

$56.35

-0.1 (-0.18%)

06:29
10/16/19
10/16
06:29
10/16/19
06:29
Hot Stocks
Amazon says consumer business turns off final Oracle database »

Amazon (AMZN) said in a…

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

ORCL

Oracle

$56.35

-0.1 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

BTI

British American Tobacco

$34.60

0.245 (0.71%)

, MO

Altria Group

$43.43

0.72 (1.69%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Periodicals
Congress probes whether e-cig manufacturers paid for spam bots, WSJ reports »

Congress has launched an…

BTI

British American Tobacco

$34.60

0.245 (0.71%)

MO

Altria Group

$43.43

0.72 (1.69%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$78.32

0.28 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

RYAM

Rayonier Advanced Materials

$4.70

0.21 (4.68%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Downgrade
Rayonier Advanced Materials rating change  »

Rayonier Advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:26
10/16/19
10/16
06:26
10/16/19
06:26
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:24
10/16/19
10/16
06:24
10/16/19
06:24
Syndicate
Rhythm Pharmaceuticals 8.11M share Spot Secondary priced at $18.50 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
ProQR Therapeutics 9.091M share Spot Secondary priced at $5.50 »

Citi and Evercore ISI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SSNLF

Samsung

$0.00

(0.00%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Periodicals
Samsung places further EUV equipment orders, DigiTimes reports »

Samsung Electronics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
Rhythm Pharmaceuticals 8.108M share Spot Secondary priced at $18.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

06:22
10/16/19
10/16
06:22
10/16/19
06:22
Syndicate
Principia Biopharma 7.5M share Spot Secondary priced at $28.00 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

EURN

Euronav NV

$10.72

-0.605 (-5.34%)

06:21
10/16/19
10/16
06:21
10/16/19
06:21
Recommendations
Euronav NV analyst commentary  »

Euronav a good play on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BA

Boeing

$370.99

-2.05 (-0.55%)

, EADSY

Airbus

$0.00

(0.00%)

06:20
10/16/19
10/16
06:20
10/16/19
06:20
Periodicals
Entry date for Boeing's 777-8 depending on customer demand, Reuters reports »

The date of entry into…

BA

Boeing

$370.99

-2.05 (-0.55%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.